AzTrials
AzTrials

Anxiety, SocialNCT04790864

An Online Large-group One-session Treatment for Public Speaking Anxiety

A study testing Online large-group one-session treatment with post-treatment exercise targeting expectancy violation in people with Anxiety, Social, run by Ruhr University of Bochum at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Different conceptualizations of public speaking anxiety exist to which it can be either considered as a qualitatively distinct subtype of social phobia or a quantitatively less severe form of a more impairing generalized social phobia. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anxiety, Social
What is being tested?
Online large-group one-session treatment with post-treatment exercise targeting expectancy violation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteGermany
Study dates
1 Jan 2021to 4 Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 18 years or above
  • participants self-screen their public speaking anxiety and generalized social anxiety; participation is recommended if public speaking anxiety is moderate to high and if generalized social anxiety is low (this criterion is not explicitly checked by the investigator as there is only a recommendation and participants can register even though they do not receive a recommendation for participation)

Who cannot join

  • Not having the appropriate technical equipment for participation in a videoconference

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Ruhr-University of Bochum

    Bochum, 44801

Other trials in Germany

About this study

Official title: Speaking Out Against Anxiety: Feasibility and Efficacy of an Online Large-group One-session Treatment for Public Speaking Anxiety and the Role of Expectancy Violation

Different conceptualizations of public speaking anxiety exist to which it can be either considered as a qualitatively distinct subtype of social phobia or a quantitatively less severe form of a more impairing generalized social phobia. However, the prevalence of public speaking fears can be regarded as high and there is considerable evidence for interference with work or education. In addition, public speaking anxiety can cause marked distress suggesting that the impairment, at least in some individuals, is high enough to warrant professional treatment. Cognitive behavioral therapy (CBT) has turned out as an effective treatment for social phobia in general but also for public speaking anxiety. Nevertheless, some aspects hinder the successful delivery of CBT to anxious individuals. On the one hand, individuals are sometimes uncertain if the severity of their symptoms and impairment justifies professional treatment. On the other hand, groups are required for conducting exposure interventions.

This study tries to circumvent these limitations by lowering the access to treatment and by providing treatment in a group of anxious individuals. Large-group one-session treatments have been shown to be feasible in the treatment of specific phobias and fears and investigations revealed first evidence regarding their efficacy.

Read more

The COVID-19 pandemic makes it impossible to conduct face-to-face group sessions, so an online setting making use of a videoconference tool has been chosen.

In this study, the investigators plan to conduct an online large-group one-session treatment to reduce public speaking anxiety comprising different cognitive and behavioral techniques. First, anxiety and its function in general as well as factors causing, defining and maintaining public speaking anxiety are addressed in a psychoeducation phase. Second, different speaking tasks are conducted to expose the individuals to their feared situation on the one hand and to address common cognitive processes characterizing public speaking anxiety, e.g. self-focused attention, on the other hand. The exercises will be conducted in smaller groups.

Participants will be recruited from a community sample. They are invited to self-screen their public speaking anxiety to see if the intervention is suitable for them. The only exclusion criterion is not having the appropriate technical equipment for participation in a videoconference.

Public speaking anxiety as well as cognitive facets of social phobia will be assessed two months before treatment, two days before and one day after treatment and at one month and six months follow up to investigate long-term effects of the intervention.

Besides the aim of supporting a general feasibility and efficacy of the intervention, the study focusses on the role of expectancy violation. Recent theoretical frameworks suggest that expectancy violation is the core mechanism behind successful exposure therapy. Nevertheless, only a few studies to date manipulated expectancy violation experimentally to confirm its importance. Thus, participants in this study will be randomly allocated to two different treatment conditions. After completion of the treatment, one half of the participants will elaborate a worksheet that addresses basic contentual information concerning the treatment without a specific attempt to highlight the discrepancy between anticipated and actual outcomes. For example, participants will be asked how they would explain public speaking anxiety and exposure therapy to a friend and what advantages they see in conducting treatments like this in groups (BASIC task). The other group will receive a worksheet with questions aimed at enhancing the processing of what was learned during treatment in terms of expectancy violation. For example, they are asked if what they were most worried about occured and what actually happened compared to what they predicted to happen (EV task).

Read the detailed description

Comprising both groups, the investigators expect a reduction in public speaking anxiety. This effect should be present comparing pre-treatment anxiety to the anxiety reported at the assessment points directly after treatment, one month after treatment and six months after treatment. The change in reported anxiety between the two assessment time points before treatment is used as a control condition as there is no waitlist control group that is assessed but not treated. The reduction in public speaking anxiety is expected to be larger when comparing the assessments before and after treatment than in the control period before treatment. Furthermore, the investigators hypothesize participants to benefit from the intervention in terms of other constructs, namely socially phobic cognitions and fear of negative evaluation.

Besides the hypotheses regarding general efficacy of the intervention, the investigators expect the reduction in public speaking anxiety in the EV group to be larger than in the BASIC group. This superiority of the EV condition should be present at the assessment points directly after treatment, one month after treatment and six months after treatment.

The sample under investigation will be a sample of anxious individuals recruited from the community. All participants can attain the intervention for free and there is no payment for participation. On a website created for the project, interested parties can receive information on the project and can self-screen their public speaking anxiety and generalized social anxiety. Participation is recommended if public speaking anxiety is high and if general social phobia is low. After registration for the study, participants are asked to fill out a survey through a link sent to them via e-mail. This survey comprises all outcome measures. The same procedure is carried out two days before, one day after, one month after and six months after treatment.

The target sample size is 100 participants. The decision for that number is not based on power calculations as there was no study before that conducted an online large-group one-session intervention for the treatment of public speaking anxiety and therefore effect size estimates would be random. Instead, the target sample size can be ascribed to organizational purposes.

In terms of the general efficacy hypothesis, the primary outcome measure will be analyzed with a repeated measures ANOVA covering the assessment time points after registration, two days before and one month after treatment.

For all other outcome measures, the investigators will use a rmANOVA comprising all five assessment time points, i.e. after registration, two days before the intervention, one day after the intervention, one month after the intervention and six months after the intervention. Furthermore, there will be paired comparisons between the public speaking anxiety scores at each of the assessment time points.

These analyses will be conducted not only for public speaking anxiety but also for social phobic cognitions, fear of negative evaluation and other psychological constructs such as positive mental health.

Regarding the expectancy violation hypothesis, the primary outcome measure will be analyzed with a 2x3 repeated measures ANOVA. For all other outcome measures, the investigators will use 2x5 between-within repeated measures ANOVAs (rmANOVA) to analyze the results. The first factor is a between-subjects factor that comprises the two groups BASIC and EV. The second factor is a within-subjects factor reflecting the five assessment time points after registration for the study, two days before the intervention, one day after the intervention, one month after the intervention and six months after the intervention. This analysis will be conducted for public speaking anxiety, social phobic cognitions and fear of negative evaluation. Moreover, there will be paired comparisons between the two groups for each of the assessment time points.

Conditions
Anxiety, Social
Being tested
Online large-group one-session treatment with post-treatment exercise targeting expectancy violation, Online large-group one-session treatment with post-treatment control exercise
Keywords
large-group treatment, one-session treatment, online intervention, public speaking anxiety, expectancy violation
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Online large-group one-session treatment with post-treatment exercise targeting expectancy violationBehavioural

    The treatment is aimed at reducing public speaking anxiety by using cognitive and behavioral techniques. Following a psychoeducation phase, different speaking tasks are conducted to expose the individuals to their feared situation on the one hand and to address common cognitive processes characterizing public speaking anxiety, e.g. self-focused attention, on the other hand. The exercises will be conducted in smaller groups. After treatment, participants receive a worksheet with questions aimed at enhancing the processing of what was learned during treatment in terms of expectancy violation. For example, they are asked if what they were most worried about occured and what actually happened compared to what they predicted to happen. This should highlight the discrepancy between anticipated and actual outcomes. The intervention is conducted in an online group format via videoconference with a duration of approximately 5 hours.

  • Online large-group one-session treatment with post-treatment control exerciseBehavioural

    The treatment is aimed at reducing public speaking anxiety by using cognitive and behavioral techniques. Following a psychoeducation phase, different speaking tasks are conducted to expose the individuals to their feared situation on the one hand and to address common cognitive processes characterizing public speaking anxiety, e.g. self-focused attention, on the other hand. The exercises will be conducted in smaller groups. After treatment, participants receive a worksheet that addresses basic contentual information concerning the treatment without a specific attempt to highlight the discrepancy between anticipated and actual outcomes. For example, participants will be asked how they would explain public speaking anxiety and exposure therapy to a friend and what advantages they see in conducting treatments like this in groups. The intervention is conducted in an online group format via videoconference with a duration of approximately 5 hours.

Study groups in NCT04790864
Study groupRoleWhat they receive
Online large-group one-session treatment with post-treatment exercise targeting expectancy violationExperimentalNot described
Receives: Behavioral: Online large-group one-session treatment with post-treatment exercise targeting expectancy violation
Online large-group one-session treatment with post-treatment control exerciseActive comparatorNot described
Receives: Behavioral: Online large-group one-session treatment with post-treatment control exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change on self statements during public speaking scale (german version; Hofmann & Heinrichs, 2001)

    10 items, 6-point Likert scale (0 - 5), large change in a negative direction means better outcome

    Measured: two days before the intervention and one month after the intervention [compared to the change between the assessment time points after registration and two days before treatment]

Secondary outcomes (3)
  1. change on self statements during public speaking scale (german version; Hofmann & Heinrichs, 2001)

    10 items, 6-point Likert scale (0 - 5), large change in a negative direction means better outcome

    Measured: after registration for the study, two days before the intervention, one day after the intervention, one month after the intervention (already specified as primary outcome measure), six months after the intervention

  2. change on social cognitions questionnaire (german version; Stangier, Heidenreich, Ehlers, & Clark, 1996)

    22 items, two questions regarding each item; 1st: frequency of thoughts, 5-point Likert scale (1 - 5), large change in a negative direction means better outcome; 2nd: degree of confidence, that the content of the cognition is correct, 0-100, large change in a negative direction means better outcome

    Measured: after registration for the study, two days before the intervention, one day after the intervention, one month after the intervention, six months after the intervention

  3. change on fear of negative evaluation scale short form (german version; Kemper, Lutz, & Neuser, 2011)

    5 items, 4-point Likert scale (1 - 4), large change in a negative direction means better outcome

    Measured: after registration for the study, two days before the intervention, one day after the intervention, one month after the intervention, six months after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2021
  2. Study start1 Jan 2021
  3. Primary completion1 May 2021
  4. Study completion4 Oct 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04790864
Sponsor's protocol ID
684
Status last verified
Apr 2022
First submitted
5 Mar 2021
Last updated
27 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: It is planned to make individual participant data available on publication of the associated study results, via a publically-available data repository such as Open Science Framework. Data made available will be the research data reported in the publication, with the exception of any data that could compromise participant anonymity.

Questions about this trial

What is this clinical trial studying?

A study testing Online large-group one-session treatment with post-treatment exercise targeting expectancy violation in people with Anxiety, Social, run by Ruhr University of Bochum at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change on self statements during public speaking scale (german version; Hofmann & Heinrichs, 2001) (time frame: two days before the intervention and one month after the intervention [compared to the change between the assessment time points after registration and two days before treatment]). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in